In a new study, researchers examined four randomized controlled trials of belimumab (Benlysta®) to gain a better ...

Kezar Life Sciences announced the termination of Phase 2b PALIZADE clinical trial of zetomipzomib, an investigational therapy ...

The Lupus Foundation of America (LFA) is excited to announce Karen Costenbader is the recipient of the LFA’s 2024 Predict and Prevent Lupus Research grant.

This Hispanic Heritage Month, we celebrate the strength, culture, and contribution of the Hispanic and Latino communities across the country. As we celebrate these vibrant communities, it’s also ...

Systemic lupus is the most common form of lupus—it’s what most people mean when they refer to “lupus.” Systemic lupus can be mild or severe. Cutaneous lupus erythematosus This form of lupus is limited ...

Walk to End Lupus Now® events provide people affected by lupus and their families with the opportunity to come together for one purpose: ending lupus. Join us in Orange County to walk together to ...

The Lupus Foundation of America works to improve the quality of life for all people affected by lupus through programs of research, education, support and advocacy. A charitable organization with ...